News & Events

Apr 20, 2022

Events

ViaCyte to Participate in 2022 Advanced Technologies & Treatments for Diabetes Conference

Dr. Manasi Jaiman, newly appointed Chief Medical Officer, to discuss patient-reported outcomes associated with cell therapy in type 1 diabetes SAN DIEGO, Calif., April 20, 2022 – Manasi Sinha Jaiman, M.D., M.P.H., who was recently appointed Chief Medical Officer at ViaCyte, Inc., a clinical-stage cellular therapy company with an advanced stem cell platform that delivers […]

Read More
Feb 2, 2022 Press Releases

CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)

Read More
Jan 19, 2022 Press Releases

ViaCyte Strengthens Management Team with Appointment of Alyssa Levin as Chief Financial Officer and Addition of Lisa Porter, MD, to the Board of Directors

Read More
Dec 3, 2021 Press Releases

ViaCyte Chief Scientific Officer to Deliver Keynote Address at JDRF Mission Summit

Read More
Dec 2, 2021 Press Releases

ViaCyte’s Stem Cell-Derived Treatment for Type 1 Diabetes Shows Promising Results in Two Published Studies

Read More
Load More

Media Materials

 

Media Contact

Sign up for updates

To have our press releases and major updates sent to you, please provide your name and email address.